Skip to Content

Luzu Approval History

FDA Approved: Yes (First approved November 14, 2013)
Brand name: Luzu
Generic name: luliconazole
Dosage form: Topical Cream
Company: Bausch Health Companies Inc.
Treatment for: Tinea Corporis, Tinea Pedis, Tinea Cruris

Luzu (luliconazole) Cream is an azole antifungal indicated for the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis.

Development History and FDA Approval Process for Luzu

DateArticle
Feb 22, 2018Approval FDA Approves Expanded Use of Luzu (luliconazole) Cream in Pediatric Patients with Athlete’s Foot, Jock Itch and Ringworm
Nov 15, 2013Approval Valeant Pharmaceuticals Announces U.S. Approval Of Luzu Cream, 1%

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide